• An Erratum to this article was published on 19 July 2017
  • An Erratum to this article was published on 18 October 2017

This article has been updated


Gut dysbiosis might underlie the pathogenesis of type 1 diabetes. In mice of the non-obese diabetic (NOD) strain, we found that key features of disease correlated inversely with blood and fecal concentrations of the microbial metabolites acetate and butyrate. We therefore fed NOD mice specialized diets designed to release large amounts of acetate or butyrate after bacterial fermentation in the colon. Each diet provided a high degree of protection from diabetes, even when administered after breakdown of immunotolerance. Feeding mice a combined acetate- and butyrate-yielding diet provided complete protection, which suggested that acetate and butyrate might operate through distinct mechanisms. Acetate markedly decreased the frequency of autoreactive T cells in lymphoid tissues, through effects on B cells and their ability to expand populations of autoreactive T cells. A diet containing butyrate boosted the number and function of regulatory T cells, whereas acetate- and butyrate-yielding diets enhanced gut integrity and decreased serum concentration of diabetogenic cytokines such as IL-21. Medicinal foods or metabolites might represent an effective and natural approach for countering the numerous immunological defects that contribute to T cell–dependent autoimmune diseases.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 05 April 2017

    In the version of this article initially published online, the callout for Figure 4g was incorrectly attributed, and Figure 5d was displayed incorrectly. The errors have been corrected in the print, PDF and HTML versions of the article.

  • 08 May 2017

    In the version of this article initially published, the graph curves in Figure 2b were displayed incorrectly. The error has been corrected in the HTML and PDF versions of the article.

  • 20 September 2017

    In the supplementary information originally posted online, Supplementary Tables 2 and 3 were missing titles and legends. The error has been corrected in this file as of 20 September 2017.


Primary accessions

Gene Expression Omnibus


  1. 1.

    , & Type 1 diabetes. Lancet 383, 69–82 (2014).

  2. 2.

    et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842–853 (2016).

  3. 3.

    et al. Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice. Nat. Microbiol. 1, 16140 (2016).

  4. 4.

    , & Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40, 833–842 (2014).

  5. 5.

    & Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5–9 (2011).

  6. 6.

    et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455, 1109–1113 (2008).

  7. 7.

    et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013).

  8. 8.

    et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).

  9. 9.

    et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).

  10. 10.

    et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).

  11. 11.

    et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543–547 (2011).

  12. 12.

    et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).

  13. 13.

    et al. Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood 122, 2823–2836 (2013).

  14. 14.

    Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345–352 (2005).

  15. 15.

    , , , & Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc. Natl. Acad. Sci. USA 102, 17729–17733 (2005).

  16. 16.

    , & The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57, 2555–2562 (2008).

  17. 17.

    et al. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62, 1238–1244 (2013).

  18. 18.

    et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006–2014 (2014).

  19. 19.

    et al. Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways. Cell Rep. 15, 2809–2824 (2016).

  20. 20.

    & Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 81, 1031–1064 (2001).

  21. 21.

    , , , & Effects of high-amylose maize starch and butyrylated high-amylose maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis 29, 2190–2194 (2008).

  22. 22.

    et al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534, 213–217 (2016).

  23. 23.

    et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739–742 (2000).

  24. 24.

    , , , & B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes 61, 2893–2905 (2012).

  25. 25.

    , , & Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice. Eur. J. Immunol. 36, 1951–1962 (2006).

  26. 26.

    , , & Transcriptional regulation of antigen presentation. Curr. Opin. Immunol. 16, 67–75 (2004).

  27. 27.

    & Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 26, 133–169 (2008).

  28. 28.

    et al. Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. J. Leukoc. Biol. 71, 238–246 (2002).

  29. 29.

    et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 6, 7320 (2015).

  30. 30.

    , & How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532 (2008).

  31. 31.

    et al. Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling. J. Mol. Endocrinol. 53, 367–380 (2014).

  32. 32.

    et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6, 6734 (2015).

  33. 33.

    et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58, 1144–1155 (2009).

  34. 34.

    , , , & IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 105, 14028–14033 (2008).

  35. 35.

    & Role of glutamate metabolism in bacterial responses towards acid and other stresses. J. Appl. Microbiol. 114, 11–24 (2013).

  36. 36.

    et al. CD4+CD25+ T-cells control autoimmunity in the absence of B-cells. Diabetes 58, 1568–1577 (2009).

  37. 37.

    et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2, 645–653 (1995).

  38. 38.

    et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260–273 (2015).

  39. 39.

    & Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 62, 67–72 (2003).

  40. 40.

    et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).

  41. 41.

    et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. USA 109, E2865–E2874 (2012).

  42. 42.

    et al. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. J. Immunol. 193, 5933–5950 (2014).

  43. 43.

    et al. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J. Clin. Invest. 118, 2562–2573 (2008).

  44. 44.

    et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br. J. Nutr. 114, 220–230 (2015).

  45. 45.

    , , & Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat. Br. J. Nutr. 96, 276–282 (2006).

  46. 46.

    & Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107, 12204–12209 (2010).

  47. 47.

    et al. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur. J. Immunol. 44, 983–993 (2014).

  48. 48.

    et al. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J. Clin. Invest. 120, 1324–1336 (2010).

  49. 49.

    , , , & At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies. Appl. Environ. Microbiol. 71, 7724–7736 (2005).

  50. 50.

    , , , & Fast, accurate error-correction of amplicon pyrosequences using Acacia. Nat. Methods 9, 425–426 (2012).

  51. 51.

    et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069–5072 (2006).

  52. 52.

    et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2, 6 (2014).

  53. 53.

    et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57, 395–404 (2008).

  54. 54.

    et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

  55. 55.

    , & The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).

  56. 56.

    , & edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).

  57. 57.

    et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617–1632 (2012).

Download references


We thank S. Akira (Osaka University) for Myd88−/− mice; D.R. Powell, S. Archer, Deltagen, B. Scherer, H. Thomas, G. Jhala, L. Mason, H.Y. Goh, M. Udugama, F. Lim, Y.A. Leong, C. Ang Kim Lian, C. McKenzie and Monash Animal Services for assistance; the NIH Tetramer Facility for the IGRP and BDC2.5 tetramers; and the Monash Histology Platform of Monash University. Supported by the Juvenile Diabetes Research Foundation (3-2013-94), the Diabetes Australia Research Trust (Y14M1-MARE), and the Australian National Health and Medical Research Council (program grant 1016953 and Australia Fellowship 606947).

Author information


  1. Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Clayton, Australia.

    • Eliana Mariño
    • , James L Richards
    • , Keiran H McLeod
    • , Yu Anne Yap
    • , Jacinta Knight
    • , Craig McKenzie
    • , Laurence Macia
    • , Alison Thorburn
    • , Lee H Wong
    •  & Charles R Mackay
  2. Central Queensland University, School of Medical and Applied Sciences, Rockhampton, Australia.

    • Dragana Stanley
  3. Institute for Immunology, Ludwig Maximilians University, Munich, Munich, Germany.

    • Jan Kranich
  4. Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

    • Ana Carolina Oliveira
  5. Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia.

    • Fernando J Rossello
    • , Christian M Nefzger
    •  & Jose M Polo
  6. Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Clayton, Australia.

    • Fernando J Rossello
    • , Christian M Nefzger
    •  & Jose M Polo
  7. Australian Regenerative Medicine Institute, Monash University, Clayton, Australia.

    • Fernando J Rossello
    • , Christian M Nefzger
    •  & Jose M Polo
  8. Islet Biology Laboratory, St Vincent's Institute, Fitzroy, Australia.

    • Balasubramanian Krishnamurthy
  9. Nutritional Immunometabolism Node Laboratory, Charles Perkins Centre, University of Sydney, Sydney, Australia.

    • Laurence Macia
  10. School of Medical Sciences, University of Sydney, Sydney, Australia.

    • Laurence Macia
  11. Comparative Genomics Centre, Molecular Sciences, James Cook University, Townsville, Australia.

    • Alan G Baxter
  12. Harry Perkins Institute for Medical Research, Nedlands, Australia.

    • Grant Morahan
  13. Infection and Immunity Program, Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Australia.

    • Robert J Moore
  14. School of Science, RMIT University, Bundoora West Campus, Bundoora, Australia.

    • Robert J Moore
  15. CSIRO Health and Biosecurity, North Ryde, Australia.

    • Trevor J Lockett
  16. CSIRO Health and Biosecurity, Adelaide, Australia.

    • Julie M Clarke
    •  & David L Topping
  17. Walter & Eliza Hall Institute of Medical Research, Parkville, Australia.

    • Leonard C Harrison


  1. Search for Eliana Mariño in:

  2. Search for James L Richards in:

  3. Search for Keiran H McLeod in:

  4. Search for Dragana Stanley in:

  5. Search for Yu Anne Yap in:

  6. Search for Jacinta Knight in:

  7. Search for Craig McKenzie in:

  8. Search for Jan Kranich in:

  9. Search for Ana Carolina Oliveira in:

  10. Search for Fernando J Rossello in:

  11. Search for Balasubramanian Krishnamurthy in:

  12. Search for Christian M Nefzger in:

  13. Search for Laurence Macia in:

  14. Search for Alison Thorburn in:

  15. Search for Alan G Baxter in:

  16. Search for Grant Morahan in:

  17. Search for Lee H Wong in:

  18. Search for Jose M Polo in:

  19. Search for Robert J Moore in:

  20. Search for Trevor J Lockett in:

  21. Search for Julie M Clarke in:

  22. Search for David L Topping in:

  23. Search for Leonard C Harrison in:

  24. Search for Charles R Mackay in:


E.M. and C.R.M. formulated different elements of the study and wrote the manuscript; E.M. supervised the experimental work and performed flow cytometry, adoptive-transfer experiments and sorting of cells; J.L.R. performed flow cytometry, disease-incidence studies, analysis of pancreata histology and assignment of insulitis scores; K.H.M. performed adoptive-transfer studies, single-sorting experiments, qPCR and GF disease-incidence studies and assisted D.S. in microbiota studies; Y.A.Y. performed flow cytometry of colon samples, in vitro experiments and extraction of fecal DNA; J. Knight. performed flow cytometry; J. Knight and J. Kranich performed disease-incidence studies; C.M. and L.H.W. performed chromatin-immunoprecipitation studies; A.C.O. performed ELISA; F.J.R. did bioinformatics; B.K. provided NOD.Foxp3-GFP mice; C.M.N. performed real-time PCR analysis and Treg cell single-cell expression analysis; L.M. and A.T. edited the manuscript; A.G.B. provided Myd88−/− mice; G.M. performed and assisted with genome-wide studies of single-nucleotide polymorphisms; J.M.P. did bioinformatics and gene-expression analysis; R.J.M. sequenced fecal bacteria DNA; T.J.L., J.M.C. and D.L.T. provided the diets and assisted with intellectual input; L.C.H. performed GF studies and manuscript editing; C.R.M. conceived of and initiated the overall project and provided the overarching hypothesis; and all authors provided specialized technical or intellectual support to the project.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Eliana Mariño or Charles R Mackay.

Integrated supplementary information

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–7 and Supplementary Tables 1–3

About this article

Publication history






Further reading